Use of bortezomib as adjunctive therapy for densensitization in combined heart and kidney transplantation--a case report.
Heart Transplant Program, Cedars-Sinai Heart Institute, Beverly Hills, California, USA.
Jignesh K
JK
Patel
Matthew J
MJ
Everly
Michelle
M
Kittleson
Jon A
JA
Kobashigawa
D001323:Autoantibodies / Q000097:blood; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D003888:Desensitization, Immunologic / Q000379:methods*; D005434:Flow Cytometry; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D011480:Protease Inhibitors / Q000627:therapeutic use*; D011719:Pyrazines / Q000627:therapeutic use*
D001323:Autoantibodies; D001897:Boronic Acids; D016756:Immunoglobulins, Intravenous; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib